Health

Results: 1813-1824 of 6448

Set to complete in 2027, the state-of-the-art iREACH Health clinical research center is set to become a cornerstone of Northern Ireland's life sciences landscape. As part of this development, Celerion will relocate its U.K. Phase 1 clinical research operations to the facility, positioning it at the forefront of clinical research innovation. (Photo: Business Wire)

Celerion Expands UK Phase 1 Clinical Research Operations With New Agreement to Relocate to Queen’s University Belfast’s iREACH Health – Clinical Research Innovation Center

Stablepharma Secures €2.5m EIC Accelerator Grant, Recognised Among Europe's Top 71 Innovators (Photo: Business Wire)

Stablepharma Secures €2.5m EIC Accelerator Grant, Recognised Among Europe's Top 71 Innovators

10-year study to shed light on youth vaping

CKGSB and Johns Hopkins University Launch AI-Driven Healthcare Innovation Program

Business Wire logo

Celltrion Expands Biosimilar Portfolio in the European Union Following European Commission Approval of Two Biosimilars

UPM's Board of Directors has approved the commencement of a new plan for the period 2025-2027 within the Performance Share Arrangement

The LetsGetChecked ImPress is only for use with compatible collection and transport devices that are cleared for use with this device. It is not intended for use as a blood collection kit. This device is not intended for at-home collection or collection by a lay user. Tube image is for illustrative purposes only. (Photo: Business Wire)

LetsGetChecked ImPress Lancing Device Receives FDA 510K Clearance

PR Newswire associated0

Berlin Heals Holding AG Successfully Raises Over 7Million CHF Round for Initiating First Studies of New Less Invasive Approaches

Business Wire logo

Novotech Partners with Wonju Severance Christian Hospital to Drive Clinical Research Excellence in Korea

PR Newswire associated0

Michel Lussier Joins Caristo Diagnostics Board of Directors

Petosemtamab granted Breakthrough Therapy designation by the U.S. FDA for 1L PD-L1 positive head and neck squamous cell carcinoma

Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program